$CBUS
Cibus, Inc.

2018 Q3 Form 10-Q Financial Statement

#000119312518235110 Filed on August 01, 2018

View on sec.gov

Income Statement

Concept 2018 Q3 2018 Q2 2017 Q2
Revenue $27.00K $196.0K $223.0K
YoY Change -38.64% -12.11% 92.24%
Cost Of Revenue $0.00 $0.00 $0.00
YoY Change -100.0%
Gross Profit $27.00K $196.0K $223.0K
YoY Change -38.64% -12.11% 1293.75%
Gross Profit Margin 100.0% 100.0% 100.0%
Selling, General & Admin $3.311M $4.595M $2.010M
YoY Change -49.47% 128.61% 67.22%
% of Gross Profit 12262.96% 2344.39% 901.35%
Research & Development $3.440M $3.093M $1.453M
YoY Change -46.57% 112.87% 11.26%
% of Gross Profit 12740.74% 1578.06% 651.57%
Depreciation & Amortization $356.0K $215.0K $134.0K
YoY Change 143.84% 60.45% 793.33%
% of Gross Profit 1318.52% 109.69% 60.09%
Operating Expenses $7.726M $7.688M $3.463M
YoY Change -40.53% 122.0% 38.08%
Operating Profit -$7.699M -$7.492M -$3.240M
YoY Change -40.53% 131.23% 30.02%
Interest Expense $349.0K -$72.00K -$30.00K
YoY Change 627.08% 140.0% -1600.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$7.483M -$7.576M -$3.395M
YoY Change -42.01% 123.15% 38.18%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$7.483M -$7.576M -$3.395M
YoY Change -42.01% 123.15% 38.18%
Net Earnings / Revenue -27714.81% -3865.31% -1522.42%
Basic Earnings Per Share
Diluted Earnings Per Share -$231.0K -$254.0K -$173.5K
COMMON SHARES
Basic Shares Outstanding 32.35M shares 28.02M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q3 2018 Q2 2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $101.8M $105.6M $2.500M
YoY Change 62.88% 4124.0%
Cash & Equivalents $101.8M $105.6M $2.521M
Short-Term Investments
Other Short-Term Assets $1.100M $1.500M $2.700M
YoY Change 175.0% -44.44%
Inventory
Prepaid Expenses
Receivables $0.00 $0.00 $0.00
Other Receivables $200.0K $100.0K $100.0K
Total Short-Term Assets $103.0M $107.2M $5.323M
YoY Change 63.3% 1913.85%
LONG-TERM ASSETS
Property, Plant & Equipment $21.31M $21.34M $11.33M
YoY Change 74.72% 88.26%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $341.0K $307.0K $280.0K
YoY Change 7.57% 9.64%
Total Long-Term Assets $21.65M $21.64M $11.61M
YoY Change 73.02% 86.36%
TOTAL ASSETS
Total Short-Term Assets $103.0M $107.2M $5.323M
Total Long-Term Assets $21.65M $21.64M $11.61M
Total Assets $124.6M $128.8M $16.94M
YoY Change 64.91% 660.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.240M $1.110M $1.910M
YoY Change 120.64% -41.88%
Accrued Expenses $2.669M $1.959M $732.0K
YoY Change 319.65% 167.62%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.869M $5.042M $8.900M
YoY Change 35.03% -43.35%
LONG-TERM LIABILITIES
Long-Term Debt $17.40M $17.40M $0.00
YoY Change 120.25%
Other Long-Term Liabilities $100.0K $100.0K $500.0K
YoY Change -75.0% -80.0%
Total Long-Term Liabilities $17.50M $17.50M $500.0K
YoY Change 110.84% 3400.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.869M $5.042M $8.900M
Total Long-Term Liabilities $17.50M $17.50M $500.0K
Total Liabilities $24.39M $22.60M $9.353M
YoY Change 81.21% 141.66%
SHAREHOLDERS EQUITY
Retained Earnings -$73.98M -$66.49M -$34.80M
YoY Change 55.09% 91.1%
Common Stock $174.2M $172.7M $42.38M
YoY Change 58.64% 307.59%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $100.2M $106.2M $7.584M
YoY Change
Total Liabilities & Shareholders Equity $124.6M $128.8M $16.94M
YoY Change 64.91% 660.71%

Cashflow Statement

Concept 2018 Q3 2018 Q2 2017 Q2
OPERATING ACTIVITIES
Net Income -$7.483M -$7.576M -$3.395M
YoY Change -42.01% 123.15% 38.18%
Depreciation, Depletion And Amortization $356.0K $215.0K $134.0K
YoY Change 143.84% 60.45% 793.33%
Cash From Operating Activities -$4.770M -$2.260M -$2.350M
YoY Change 149.74% -3.83% 312.28%
INVESTING ACTIVITIES
Capital Expenditures -$330.0K -$460.0K -$300.0K
YoY Change -67.0% 53.33% -91.23%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$330.0K -$460.0K -$300.0K
YoY Change -67.0% 53.33% -91.23%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.330M 57.63M 2.170M
YoY Change -97.89% 2555.76%
NET CHANGE
Cash From Operating Activities -4.770M -2.260M -2.350M
Cash From Investing Activities -330.0K -460.0K -300.0K
Cash From Financing Activities 1.330M 57.63M 2.170M
Net Change In Cash -3.770M 54.91M -480.0K
YoY Change -106.28% -11539.58% -87.97%
FREE CASH FLOW
Cash From Operating Activities -$4.770M -$2.260M -$2.350M
Capital Expenditures -$330.0K -$460.0K -$300.0K
Free Cash Flow -$4.440M -$1.800M -$2.050M
YoY Change 387.91% -12.2% -171.93%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
275000000 shares
CY2018Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32336106 shares
CY2018Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
32346355 shares
CY2017Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2521000
CY2017Q3 us-gaap Lessee Finance Lease Renewal Term1
LesseeFinanceLeaseRenewalTerm1
P5Y
CY2017Q3 us-gaap Lessee Finance Lease Term Of Contract1
LesseeFinanceLeaseTermOfContract1
P20Y
CY2017Q3 clxt Number Of Lease Extension Options
NumberOfLeaseExtensionOptions
4 Options
CY2018Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1959000
CY2018Q2 us-gaap Assets Current
AssetsCurrent
107197000
CY2018Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
9000
CY2018Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0
CY2018Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1469000
CY2018Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
172730000
CY2018Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1110000
CY2018Q2 us-gaap Assets
Assets
128841000
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
105620000
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
105620000
CY2018Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2018Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32336106 shares
CY2018Q2 us-gaap Common Stock Value
CommonStockValue
3000
CY2018Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
9000
CY2018Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
116000
CY2018Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
1337000
CY2018Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
627000
CY2018Q2 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
102000
CY2018Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
3700000
CY2018Q2 us-gaap Liabilities Current
LiabilitiesCurrent
5042000
CY2018Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
363000
CY2018Q2 us-gaap Liabilities
Liabilities
22602000
CY2018Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
128841000
CY2018Q2 us-gaap Minimum Net Worth Required For Compliance
MinimumNetWorthRequiredForCompliance
300000000
CY2018Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
307000
CY2018Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2018Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21337000
CY2018Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2018Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2018Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1475000
CY2018Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2018Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
22806000
CY2018Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-66494000
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
15636000
CY2018Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
15977000
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1361055 shares
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
7.13
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3383258 shares
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.74
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
30864000
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
106239000
CY2018Q2 clxt Capital Leases Obligations And Financing Leases Noncurrent
CapitalLeasesObligationsAndFinancingLeasesNoncurrent
17444000
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5026000
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
893000
CY2017Q4 us-gaap Assets Current
AssetsCurrent
57457000
CY2017Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
3000
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1283000
CY2017Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
112021000
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1023000
CY2017Q4 us-gaap Assets
Assets
72167000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
56664000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
56664000
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
275000000 shares
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27718780 shares
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27718780 shares
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
3000
CY2017Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
43000
CY2017Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
289000
CY2017Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
1350000
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
945000
CY2017Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
167000
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4254000
CY2017Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
4000
CY2017Q4 us-gaap Liabilities
Liabilities
14691000
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
72167000
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
357000
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14353000
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
626000
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2017Q3 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
58000000
CY2017Q3 us-gaap Sale Leaseback Transaction Net Proceeds Financing Activities
SaleLeasebackTransactionNetProceedsFinancingActivities
7000000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2505000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
0
us-gaap Costs And Expenses
CostsAndExpenses
6307000
us-gaap Depreciation
Depreciation
268000
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
45000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.32
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-54548000
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3883432 shares
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.16
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
49965000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
57476000
CY2017Q4 clxt Capital Leases Obligations And Financing Leases Noncurrent
CapitalLeasesObligationsAndFinancingLeasesNoncurrent
10148000
CY2017Q3 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
3300000
CY2017Q3 us-gaap Expense Related To Distribution Or Servicing And Underwriting Fees
ExpenseRelatedToDistributionOrServicingAndUnderwritingFees
3100000
us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Transfers Net
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersNet
0
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-154000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6227000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
284000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
448000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-178000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-110000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
369000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
10000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-44000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-608000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2166000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4063000
us-gaap Net Income Loss
NetIncomeLoss
-6227000
us-gaap Operating Income Loss
OperatingIncomeLoss
-6029000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
130000
us-gaap Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
3000000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
608000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
834000
us-gaap Profit Loss
ProfitLoss
-6227000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2719000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
278000
us-gaap Share Based Compensation
ShareBasedCompensation
692000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.425 pure
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3588000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.274 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0125 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.41
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0231 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
0
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
19600000 shares
clxt Stock Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
StockIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
1269000
clxt Increase Decrease In Due To From Related Parties Current
IncreaseDecreaseInDueToFromRelatedPartiesCurrent
1213000
clxt Unrealized Transaction Gains Losses On Related Party Activity
UnrealizedTransactionGainsLossesOnRelatedPartyActivity
156000
dei Amendment Flag
AmendmentFlag
false
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2427000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
48956000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
0
us-gaap Costs And Expenses
CostsAndExpenses
11995000
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
us-gaap Depreciation
Depreciation
371000
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
dei Document Type
DocumentType
10-Q
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
76000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.41
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
dei Entity Central Index Key
EntityCentralIndexKey
0001705843
dei Entity Incorporation State Country Name
EntityIncorporationStateCountryName
Delaware
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P4Y2M12D
dei Entity Registrant Name
EntityRegistrantName
CALYXT, INC.
dei Document Period End Date
DocumentPeriodEndDate
2018-06-30
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
552000
us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Transfers Net
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersNet
0
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-18000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11946000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
87000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
799000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-207000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
0
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1504000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-318000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-140000
us-gaap Interest Paid Net
InterestPaidNet
207000
us-gaap Long Term Purchase Commitment Amount
LongTermPurchaseCommitmentAmount
7700000
us-gaap Nature Of Operations
NatureOfOperations
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> </p> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr style="PAGE-BREAK-INSIDE: avoid"> <td valign="top" width="4%" align="left"><b>.</b></td> <td valign="top" align="left"><b>Nature of Business</b></td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> Calyxt, Inc., formerly known as Cellectis Plant Sciences, Inc., was founded in 2010 and incorporated in Delaware. The Company is headquartered in Roseville, Minnesota. The Company is a consumer-centric, food- and agriculture-focused company. Prior to the Company&#x2019;s initial public offering (IPO) on July&#xA0;25, 2017, Calyxt was a wholly owned subsidiary of Cellectis. As of June&#xA0;30, 2018, Cellectis owned approximately 70.2% of the Company&#x2019;s outstanding common stock. Calyxt&#x2019;s common stock is listed on the Nasdaq market under the ticker symbol &#x201C;CLXT&#x201D;.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"> The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form <font style="WHITE-SPACE: nowrap">10-Q</font> and Article 10 of Regulation <font style="WHITE-SPACE: nowrap">S-X.</font> Accordingly, they do not include all of the information and related notes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included in the accompanying financial statements. The results of operations for the period ended June&#xA0;30, 2018 are not necessarily indicative of the results that may be expected for the full year.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"> This interim information should be read in conjunction with the audited financial statements and notes thereto included in the Company&#x2019;s Annual Report on Form <font style="WHITE-SPACE: nowrap">10-K</font> for the year ended December&#xA0;31, 2017, which was filed with the SEC on March&#xA0;14, 2018 (the Annual Report).</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b><i>Initial Public Offering</i></b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> On July&#xA0;25, 2017, the Company completed an IPO of its common stock. The Company sold an aggregate of 8,050,000 shares of common stock at a price of $8.00 per share, including 1,050,000 shares of common stock pursuant to the exercise of the underwriters&#x2019; option to purchase additional shares. In the aggregate, the Company received net proceeds from the IPO and exercise of the overallotment option of approximately $58.0&#xA0;million, after deducting underwriting discounts and commissions of $3.1&#xA0;million and offering expenses totaling approximately $3.3&#xA0;million. As part of the IPO, Cellectis purchased 2,500,000 shares of common stock for a value of $20.0&#xA0;million, the proceeds of which are included in the net proceeds of approximately $58.0&#xA0;million. The Company used $5.7&#xA0;million of the proceeds from Cellectis to pay a portion of the outstanding obligations owed to Cellectis.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b><i>Follow-on Public Offering</i></b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> On May&#xA0;22, 2018, the Company completed a <font style="WHITE-SPACE: nowrap">follow-on</font> offering of its common stock. The Company sold an aggregate of 4,057,500 shares of common stock at a price of $15.00 per share, including 457,500 shares of common stock pursuant to the exercise of the underwriters&#x2019; option to purchase additional shares. In the aggregate, the Company received net proceeds from the <font style="WHITE-SPACE: nowrap">follow-on</font> offering and exercise of the overallotment option of approximately $57.0&#xA0;million, after deducting underwriting discounts and commissions of $3.2&#xA0;million and offering expenses totaling approximately $0.7&#xA0;million. As part of the <font style="WHITE-SPACE: nowrap">follow-on</font> offering, Cellectis purchased 550,000 shares of common stock for a value of $8.3&#xA0;million, the proceeds of which are included in the net proceeds of approximately $57.0&#xA0;million.</p> </div>
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-498000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
58282000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8828000
us-gaap Net Income Loss
NetIncomeLoss
-11946000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 Segment
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 Segment
us-gaap Operating Income Loss
OperatingIncomeLoss
-11788000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
154000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
498000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
665000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
57706000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1241000
us-gaap Profit Loss
ProfitLoss
-11946000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4186000
us-gaap Sale Leaseback Transaction Date
SaleLeasebackTransactionDate
2017-09-06
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
207000
us-gaap Share Based Compensation
ShareBasedCompensation
2427000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.547 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y4M24D
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.72
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
57041000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1241000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
5159000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
83625 shares
dei Trading Symbol
TradingSymbol
CLXT
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
13.29
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
23.03
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7809000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.409 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0245 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P8Y0M0D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
249900 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
10.27
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0282 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
2200000
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
333899 shares
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> <b>Use of Estimates</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, the Company evaluates its estimates, including those related to stock-based compensation and the valuation allowance for deferred tax assets and derivatives. The Company bases its estimates on historical experience and on various other market-specific and relevant assumptions that it believes to be reasonable under the circumstances. Actual results could differ from those estimates.</p> </div>
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
28851491 shares
clxt Stock Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
StockIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
445000
clxt Interest Income
InterestIncome
412000
clxt Increase Decrease In Due To From Related Parties Current
IncreaseDecreaseInDueToFromRelatedPartiesCurrent
47000
clxt Property And Equipment Included In Financing Lease Obligation
PropertyAndEquipmentIncludedInFinancingLeaseObligation
7096000
clxt Unrealized Transaction Gains Losses On Related Party Activity
UnrealizedTransactionGainsLossesOnRelatedPartyActivity
-6000
clxt Operating Leases Expiration Date
OperatingLeasesExpirationDate
2018-06
CY2017Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2018Q2 us-gaap Sale Leaseback Transaction Annual Rental Payments
SaleLeasebackTransactionAnnualRentalPayments
1400000
CY2018Q2 us-gaap Sale Leaseback Transaction Rent Expense
SaleLeasebackTransactionRentExpense
490000
CY2017 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
0
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35 pure
CY2017 us-gaap Long Term Purchase Commitment Amount
LongTermPurchaseCommitmentAmount
1600000
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y9M18D
CY2017Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
0
CY2017Q2 us-gaap Costs And Expenses
CostsAndExpenses
3463000
CY2017Q2 us-gaap Depreciation
Depreciation
134000
CY2017Q2 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
18000
CY2017Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.17
CY2017Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-125000
CY2017Q2 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2017Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3395000
CY2017Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-30000
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
-3395000
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3240000
CY2017Q2 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
65000
CY2017Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1453000
CY2017Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
223000
CY2017Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2010000
CY2017Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
19600000 shares
CY2018Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
0
CY2018Q2 us-gaap Costs And Expenses
CostsAndExpenses
7688000
CY2018Q2 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.03 pure
CY2018Q2 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
1.00 pure
CY2018Q2 us-gaap Depreciation
Depreciation
215000
CY2018Q2 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
27000
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.25
CY2018Q2 us-gaap Description Of Defined Contribution Pension And Other Postretirement Plans
DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans
The Company provides a 401(k) defined contribution plan (the Plan) for participation by all regular fulltime employees who have completed three months of service.
CY2018Q2 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
317000
CY2018Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-12000
CY2018Q2 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2018Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7576000
CY2018Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2018Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-72000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-7576000
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-7492000
CY2018Q2 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
77000
CY2018Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3093000
CY2018Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
196000
CY2018Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4595000
CY2018Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
29840827 shares
CY2018Q2 clxt Interest Income
InterestIncome
245000
CY2018Q2 clxt Defined Contribution Plan Additional Matching Contribution Percent Of Match
DefinedContributionPlanAdditionalMatchingContributionPercentOfMatch
0.50 pure

Files In Submission

Name View Source Status
0001193125-18-235110-index-headers.html Edgar Link pending
0001193125-18-235110-index.html Edgar Link pending
0001193125-18-235110.txt Edgar Link pending
0001193125-18-235110-xbrl.zip Edgar Link pending
clxt-20180630.xml Edgar Link completed
clxt-20180630.xsd Edgar Link pending
clxt-20180630_cal.xml Edgar Link unprocessable
clxt-20180630_def.xml Edgar Link unprocessable
clxt-20180630_lab.xml Edgar Link unprocessable
clxt-20180630_pre.xml Edgar Link unprocessable
d668501d10q.htm Edgar Link pending
d668501dex311.htm Edgar Link pending
d668501dex312.htm Edgar Link pending
d668501dex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending